Lujan Applauds a $35 Cap Commitment on Future "Green" Inhalers by AstraZeneca
December 13, 2024
December 13, 2024
WASHINGTON, Dec. 13 -- Sen. Ben Ray Lujan, D-New Mexico, issued the following news release:
Today, U.S. Senator Ben Ray Lujan (D-N.M.), a member of the Senate Committee on Health, Education, Labor and Pensions (HELP Committee), applauded AstraZeneca for its commitment to cap the cost of any future "green" inhalers at $35.
In January, Lujan and members of the HELP Committee launched an investigation into the four major manufacturers of inhalers and their effort . . .
Today, U.S. Senator Ben Ray Lujan (D-N.M.), a member of the Senate Committee on Health, Education, Labor and Pensions (HELP Committee), applauded AstraZeneca for its commitment to cap the cost of any future "green" inhalers at $35.
In January, Lujan and members of the HELP Committee launched an investigation into the four major manufacturers of inhalers and their effort . . .